VIIIX
Price
$510.47
Change
+$4.30 (+0.85%)
Updated
Jul 3 closing price
Net Assets
308.43B
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

VIIIX vs VIVIX

Header iconVIIIX vs VIVIX Comparison
Open Charts VIIIX vs VIVIXBanner chart's image
Vanguard Institutional Index Instl Pl
Price$510.47
Change+$4.30 (+0.85%)
VolumeN/A
Net Assets308.43B
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
VIIIX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VIIIX vs. VIVIX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIIIX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIIIX has more cash in the bank: 308B vs. VIVIX (189B). VIVIX pays higher dividends than VIIIX: VIVIX (2.19) vs VIIIX (1.23). VIIIX was incepted earlier than VIVIX: VIIIX (28 years) vs VIVIX (27 years). VIVIX (0.04) is less costly to investors than VIIIX (0.02). VIVIX is a more actively managed with annual turnover of: 9.00 vs. VIIIX (4.00). VIVIX has a lower initial minimum investment than VIIIX: VIVIX (5000000) vs VIIIX (100000000). VIVIX (11.41) and VIIIX (11.17) have marching annual gain over last year. VIIIX (81.57) and VIVIX (79.11) have equivalent 5 years return.
VIIIXVIVIXVIIIX / VIVIX
Total Expense Ratio0.020.0450%
Annual Report Gross Expense Ratio0.020.0450%
Fund Existence28 years27 years-
Gain YTD5.7285.609102%
Front LoadN/AN/A-
Min. Initial Investment10000000050000002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets308B189B163%
Annual Yield % from dividends1.232.1956%
Returns for 1 year11.1711.4198%
Returns for 3 years56.4434.40164%
Returns for 5 years81.5779.11103%
Returns for 10 years168.29114.45147%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KB85.701.60
+1.90%
KB Financial Group
BNL16.340.14
+0.86%
Broadstone Net Lease
EYPT9.720.06
+0.62%
EyePoint Pharmaceuticals
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc